Skip to main navigation

Skip to main content

About
- Executive Team
- Board of Directors
- How We Operate
  Quality Capabilities
- Locations
- News
Products
Contract Manufacturing
Investors
Careers
Contact
- Contact Us
- Locations

News

Overview

Site Search

Year

11/16/2022

ANI Pharmaceuticals Announces the FDA Approval and Launch of Trimethoprim Tablets USP

11/09/2022

ANI Pharmaceuticals Reports Third Quarter 2022 Financial Results; Reports Record Net Revenues

10/24/2022

ANI Pharmaceuticals to Discuss Third Quarter 2022 Financial Results on November 9, 2022, at 8:00 a.m. ET

09/12/2022

ANI Pharmaceuticals Appoints Krista Davis as Chief Human Resources Officer

08/30/2022

ANI Pharmaceuticals to Present at the H.C. Wainwright 24th Annual Global Investment Conference

08/29/2022

ANI Pharmaceuticals Announces the Launch of Prochlorperazine Maleate Tablets USP

08/16/2022

ANI Pharmaceuticals Announces FDA Approval and Imminent Launch of Dexamethasone Tablets USP

08/08/2022

ANI Pharmaceuticals Reports Second Quarter 2022 Financial Results; Reports Record Net Revenues and Raises Full-Year 2022 Net Revenue Guidance for Purified Cortrophin® Gel

08/03/2022

ANI Pharmaceuticals Announces the Launch of Acebutolol Hydrochloride Capsules USP

07/28/2022

ANI Pharmaceuticals Acquires ANDAs from Oakrum Pharma, LLC

Pagination

Current page 1
Page 2
Page 3
Next page
Last page

Displaying 1 - 10 of 26

Contact Us

INVESTOR CONTACT

In-Site Communications, Inc.
Lisa M. Wilson

212-452-2793
IR@anipharmaceuticals.com

Quick Links

SEC Filings
Investor FAQs
Information Request Form

Investor Email Alerts

Email Address *

Unsubscribe

Products
Investors
Careers
Contact Us
Privacy Policy
Terms of Use
Accessibility

© Copyright 2022 ANI Pharmaceuticals, Inc.

follow us on linkedin
follow us on youtube